What is Bio-Rad Laboratories, Inc.'s life science — net sales?

Bio-Rad Laboratories, Inc. (BIO.B) reported life science — net sales of $228.5M in Q1 2026.

How has Bio-Rad Laboratories, Inc.'s life science — net sales changed year-over-year?

Bio-Rad Laboratories, Inc.'s life science — net sales decreased by 0.0% year-over-year, from $228.6M to $228.5M.

What is the long-term trend for Bio-Rad Laboratories, Inc.'s life science — net sales?

Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s life science — net sales has grown at a -7.6% compound annual growth rate (CAGR), from $1.4B to $1.02B.

Bio-Rad Laboratories, Inc. BIO.B Life Science — Net Sales

Other segment segments

Clinical Diagnostics

$363.6M+1.9%

All Other Segments

$0-100%

Similar metrics at other companies

GLW

GLWLife Science Products — Net Sales

$228M0.0%

DCILife Sciences Segment — Net Sales

$83.5M+12.5%

RVTYLife Sciences — Segment revenue

$361.85M+6.3%

DHRLife Sciences — Sales

$1.74B+3.4%

ALife Sciences and Diagnostics Markets — Net revenue

$732M+11.9%

STELife Sciences: — Revenue

$145.8M+6.9%

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s life science — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s life science — net sales?: Bio-Rad Laboratories, Inc. (BIO.B) reported life science — net sales of $228.5M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s life science — net sales changed year-over-year?: Bio-Rad Laboratories, Inc.'s life science — net sales decreased by 0.0% year-over-year, from $228.6M to $228.5M.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s life science — net sales?: Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s life science — net sales has grown at a -7.6% compound annual growth rate (CAGR), from $1.4B to $1.02B.